Boston Scientific appoints Isabel Newton as chief medical officer of its interventional oncology and...
Boston Scientific has announced that Isabel Newton has been named chief medical officer of the company’s interventional oncology (IO) and embolization business.
The company...
CIRSE announces PreciseOnco research consortium awarded IHI grant
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) today announced that the PreciseOnco consortium has been awarded funding from the EU’s Innovative...
Instylla announces first commercial use of the Embrace hydrogel embolic system
Instylla today announced that Ripal Gandhi (Baptist Health South Florida, Coral Gables, USA) has completed the first commercial procedure using the Embrace hydrogel embolic...
Penumbra unveils latest iteration of thrombectomy system for venous thromboembolism
Penumbra has launched the Lightning Flash 3.0 computer-assisted vacuum thrombectomy (CAVT) system, a development that includes "significant upgrades" to the venous thromboembolism (VTE) platform,...
